Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis
- PMID: 27651712
- PMCID: PMC5020775
- DOI: 10.4103/0976-500X.189681
Oxcarbazepine-induced drug rash with eosinophilia and systemic symptoms syndrome presenting as exfoliative dermatitis
Abstract
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a type of severe adverse cutaneous drug reaction characterized by fever, skin eruption, hematological abnormalities, and internal organ involvement. Although anticonvulsant drugs are mainly implicated in DRESS, newer anticonvulsants such as oxcarbazepine-induced definite cases of DRESS syndrome are rare and oxcarbazepine-induced DRESS syndrome presenting as exfoliative dermatitis is even rarer. We report a case of a 35-year-old male who developed DRESS syndrome presenting as exfoliative dermatitis after taking oxcarbazepine for 3 weeks.
Keywords: Drug rash with eosinophilia and systemic symptoms; exfoliative dermatitis; oxcarbazepine.
Figures
Similar articles
-
Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.Br J Dermatol. 2013 Feb;168(2):391-401. doi: 10.1111/bjd.12081. Br J Dermatol. 2013. PMID: 23034060
-
Fluconazole-induced drug rash with eosinophilia and systemic symptoms syndrome: a case report.J Med Case Rep. 2025 May 29;19(1):257. doi: 10.1186/s13256-025-05321-z. J Med Case Rep. 2025. PMID: 40442803 Free PMC article.
-
Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).Clin Toxicol (Phila). 2008 Dec;46(10):1093-4. doi: 10.1080/15563650802342104. Clin Toxicol (Phila). 2008. PMID: 18821094
-
[Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)].Acta Med Port. 2008 Jul-Aug;21(4):367-72. Epub 2008 Oct 24. Acta Med Port. 2008. PMID: 19094812 Review. Portuguese.
-
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome in childhood: a narrative review.Front Med (Lausanne). 2023 Jul 28;10:1108345. doi: 10.3389/fmed.2023.1108345. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37575981 Free PMC article. Review.
Cited by
-
Oxcarbazepine-Induced Cutaneous Reaction in a Female of Mexican Ancestry.J Pharm Technol. 2019 Aug;35(4):179-183. doi: 10.1177/8755122519850477. Epub 2019 May 22. J Pharm Technol. 2019. PMID: 34752516 Free PMC article.
References
-
- Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: A literature review. Am J Med. 2011;124:588–97. - PubMed
-
- Fiszenson-Albala F, Auzerie V, Mahe E, Farinotti R, Durand-Stocco C, Crickx B, et al. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol. 2003;149:1018–22. - PubMed
-
- Shiohara T, Kano Y, Takahashi R. Current concepts on the diagnosis and pathogenesis of drug-induced hypersensitivity syndrome. JMAJ. 2009;52:347–52.
-
- Bosdure E, Cano A, Roquelaure B, Reynaud R, Boyer M, Viard L, et al. Oxcarbazepine and DRESS syndrome: A paediatric cause of acute liver failure. Arch Pediatr. 2004;11:1073–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources